Compare Atomera Incorporated (ATOM) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Atomera Incorporated vs Citius Pharmaceuticals Inc — how do they compare? Atomera Incorporated trades at $6.48 (market cap $241.98M), while Citius Pharmaceuticals Inc trades at $0.52 (market cap $14.83M). The key difference: Atomera Incorporated is far larger — about 16.3× Citius Pharmaceuticals Inc's market cap, and Atomera Incorporated is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| ATOM | CTXR | |
|---|---|---|
Market Cap | $241.98M | $14.83M |
Sector | Technology | Health |
52-Week High | $12.11 | $1.82 |
52-Week Low | $1.99 | $0.53 |
Enterprise Value | $202.19M | $11.05M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Atomera Incorporated
Atomera is a semiconductor materials engineering company. Its Mears Silicon Technology (MST) is a patented thin film that enhances transistor performance, power efficiency, and cost for global chip manufacturers.
Read more on ATOM →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
